MRI more effective at detecting recurrent breast cancer

the ONA take:

According to a new study published in the journal Radiology, single-screening magnetic resonance imaging (MRI) better detected recurrent breast cancer in women who had undergone breast conserving therapy (BCT) and previously had negative mammography and ultrasonographic (US) findings.


Hye Mi Gweon, MD, of the department of radiology at the Seoul National University College of Medicine in Seoul, South Korea, and colleagues found that single-screening MRI detected 18.1 additional cancers per 1000 women with a history of BCT.


The team identified 607 women with a median age of 48 between 2008 and 2012. All women underwent BCT for breast cancer, had negative mammography and US findings, and underwent a subsequent MRI. Screening with MRI detected eleven additional cancers, eight of which were invasive and three were ductal carcinoma in situ.


According to multivariate analysis, women who benefited from subsequent MRI screening were younger than 50 years old at the time of initial diagnosis and if there was a 24-month interval between initial surgery to eradicate the cancer and MRI screening. The investigators suggest that women with a history of breast cancer who underwent BCT would be the most appropriate candidates for MRI screening due to the high detection of T1 invasive cancers.

Breast MRI discovering other suspect masses
MRI detects 18.1 additional cancers after negative findings.
Single-screening breast magnetic resonance imaging (MRI) detects 18.1 additional cancers after negative findings with mammography and ultrasonography (US) per 1,000 women with a history of breast cancer, according to a study published in the August issue of Radiology.

These women had negative mammography and US findings, and most underwent preoperative MRI examinations (91.8 percent).

READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs